Published in Metabolism on August 01, 1993
Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med (1997) 1.92
Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. J Clin Invest (1996) 1.65
Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther (2010) 1.46
Tissue factor gene expression in the adipose tissues of obese mice. Proc Natl Acad Sci U S A (1998) 1.44
Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? Ther Adv Cardiovasc Dis (2008) 1.38
Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1. Am J Pathol (2003) 1.25
Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A (1999) 1.23
Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med (1996) 1.10
Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns. Arch Med Sci (2015) 0.93
Cardiometabolic aspects of polycystic ovarian syndrome. Vasc Health Risk Manag (2007) 0.93
Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis. Perit Dial Int (2013) 0.88
Preeclampsia and the future risk of hypertension: the pregnant evidence. Curr Hypertens Rep (2013) 0.80
The determinants of plasma plasminogen activator inhibitor-1 levels differ for American and Japanese men aged 40-49. Diabetes Res Clin Pract (2005) 0.78
Metabolic syndrome and sleep apnea. Hippokratia (2008) 0.78
Effects of Two Different Dietary Patterns on Inflammatory Markers, Advanced Glycation End Products and Lipids in Subjects without Type 2 Diabetes: A Randomised Crossover Study. Nutrients (2017) 0.75
Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies. Sci Rep (2016) 0.75
Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial. Trials (2015) 0.75
Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas. Crit Care (2001) 0.75
Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum (1997) 3.80
The antidiuretic action of carbamazepine in man. Clin Sci Mol Med (1974) 3.17
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum (1996) 2.96
[The hyperglycemic dehydration syndrome]. Ned Tijdschr Geneeskd (1998) 2.64
Total cholesterol and risk of mortality in the oldest old. Lancet (1997) 2.50
Plasminogen activator inhibitors. Blood (1987) 2.38
Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum (1995) 2.25
A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost (1982) 2.22
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
[Thyroid function, activities of daily living and survival in extreme old age: the 'Leiden 85-plus Study']. Ned Tijdschr Geneeskd (2006) 2.11
Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med (1998) 1.97
[Measures to prevent or delay type 2 diabetes mellitus]. Ned Tijdschr Geneeskd (2008) 1.94
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging (2006) 1.91
Identification of virilizing adrenal tumors in hirsute women. N Engl J Med (1994) 1.90
Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemost (1984) 1.72
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ (1994) 1.65
Management of severe hyponatremia: rapid or slow correction? Am J Med (1990) 1.62
Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology (2007) 1.57
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology (2011) 1.56
[An unusual complication of pneumococcal pneumonia: tamponade due to purulent pericarditis]. Ned Tijdschr Geneeskd (1995) 1.51
Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus. Neth J Med (2007) 1.48
The outcome of prolonged mechanical ventilation in elderly patients: are the efforts worthwhile? Age Ageing (1996) 1.48
Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med (1996) 1.48
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric (2011) 1.47
Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab (2001) 1.45
Tissue plasminogen activator inhibition in diabetes mellitus. Diabetes Care (1989) 1.45
Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism (1987) 1.44
Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos Int (2005) 1.42
Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res (2000) 1.42
Lactic acidosis: pathophysiology, diagnosis and treatment. Neth J Med (2001) 1.41
Diagnosing pulmonary embolism in pregnancy: rationalizing fetal radiation exposure in radiological procedures. J Thromb Haemost (2004) 1.40
Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris. Thromb Haemost (1996) 1.40
Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients. Atherosclerosis (1996) 1.40
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study. J Am Coll Cardiol (1991) 1.39
[Role of the morning report in the training of internists]. Ned Tijdschr Geneeskd (2000) 1.39
[Hyponatraenmia during a long-distance run: due to excessive fluid intake]. Ned Tijdschr Geneeskd (2007) 1.39
Purpura fulminans and symmetrical peripheral gangrene caused by Capnocytophaga canimorsus (formerly DF-2) septicemia--a complication of dog bite. Medicine (Baltimore) (1991) 1.38
[Good results of 100% oxygen treatment for acute carbon monoxide poisoning; temporarily no indication for hyperbaric oxygenation]. Ned Tijdschr Geneeskd (1993) 1.38
Large discrepancy between prostate-specific antigen results from different assays during longitudinal follow-up of a prostate cancer patient. Clin Chem (1996) 1.38
Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol (2003) 1.31
Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol (1988) 1.31
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Neurology (2009) 1.30
Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol (1988) 1.29
Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr (2002) 1.27
Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol (1995) 1.27
Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol (2001) 1.23
Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis (2003) 1.23
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest (1985) 1.22
Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry (2012) 1.22
Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology (2010) 1.22
Concentration of sex steroids in adipose tissue after menopause. Steroids (1998) 1.17
Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum (1994) 1.17
Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J Pathol (1997) 1.16
Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vasc Biol (1996) 1.15
beta-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man. Br J Clin Pharmacol (1995) 1.14
Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim Biophys Acta (1993) 1.14
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol (2012) 1.14
Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem (1986) 1.14
High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J Clin Endocrinol Metab (1986) 1.13
Adipose tissue as an endocrine organ: impact on insulin resistance. Neth J Med (2003) 1.13
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal. J Thromb Haemost (2013) 1.12
Secretory diarrhea in villous adenoma of rectum: effect of treatment with somatostatin and indomethacin. Prostaglandins (1992) 1.12
Paradoxical diuresis after vasopressin administration to patients with neurohypophyseal diabetes insipidus treated with chlorpropamide, carbamazepine or clofibrate. Clin Sci Mol Med (1975) 1.11
[And then the parrot appeared]. Ned Tijdschr Geneeskd (1986) 1.11
Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab (2002) 1.11
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease. Neurology (2009) 1.10
Determinants of C-reactive protein concentration in blood. Ital Heart J (2001) 1.10
Recurrent hypoglycaemia caused by the insulin autoimmune syndrome: the first Dutch case. Neth J Med (1996) 1.10
Circadian variation of fibrinolytic activity in blood. Chronobiol Int (1991) 1.10
Assignment of the human gene for histidine-rich glycoprotein to chromosome 3. Genomics (1990) 1.08
Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis (2003) 1.07
Spontaneous food choice in narcolepsy. Sleep (1996) 1.07
[The thiazolidinedione derivates: a new class of oral blood glucose lowering agents]. Ned Tijdschr Geneeskd (2001) 1.07
[Pneumococcal pneumonia with a fulminant course]. Ned Tijdschr Geneeskd (1992) 1.07
Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited. Ann Oncol (2001) 1.06
Improved outcome for patients with a cardiac arrest by supervision of the emergency medical services system. Neth J Med (1995) 1.05
Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology (2008) 1.05
Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP. Prostate (1993) 1.05
Body fat mass, body fat distribution, and plasma hormones in early puberty in females. J Clin Endocrinol Metab (1990) 1.04
Exophthalmos in obesity. Ophthalmic Res (2004) 1.04
A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin. Blood (1982) 1.04
Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol (Copenh) (1986) 1.04
Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf (1996) 1.04
Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech Ageing Dev (1990) 1.04
Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes Relat Metab Disord (1992) 1.03
Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation (1994) 1.02
Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. J Lab Clin Med (1978) 1.02
Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin. Cardiovasc Res (2001) 1.01
Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis (1996) 1.01
New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population. Dement Geriatr Cogn Disord (2010) 1.01
Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia (1997) 1.00
Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease. Scand J Haematol (1980) 0.99
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol (1985) 0.98
Heritability of reproductive hormones in adult male twins. Hum Reprod (2007) 0.97
The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer. Cancer (1988) 0.97
Chlorpropamide treatment in diabetes insipidus. Lancet (1967) 0.97